Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms
Fator do impacto: 1.423 FI de cinco anos: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2018028771
pages 1065-1074

Studies of the Antimicrobial Activity of Mushrooms (Agaricales) from South America (Review)

Marina Giombelli Rosenberger
Graduate Program in Botany, Federal University of Parana, Curitiba, PR, Brazil
Roberta Paulert
Department of Agronomic Sciences, Federal University of Parana, Palotina, PR, Brazil
Vagner G. Cortez
Graduate Program in Botany, Federal University of Parana, Curitiba, PR, Brazil


South America harbors much of the world's biodiversity, representing a potential reservoir of species with diverse possibilities for use. From this perspective, mushroom species are included because they naturally produce a wide variety of substances, especially ones with antimicrobial activity. In this article we present a review of the literature on the antimicrobial activity of mushrooms collected in South America, emphasizing the bacteria and fungi these mushrooms inhibit, the main methodologies researchers use for antimicrobial tests, and some directions for future research. This review demonstrates that the agar diffusion test was the most prevalent method in studies of South American mushrooms. Most studies dealt with specimens collected in Chile (16 species), Brazil (10 species), and Uruguay (2 species), and 27 of those species presented antimicrobial activity. Furthermore, most research developed with Basidiomycetes in South America aimed only to screen antimicrobial agents, whereas few studies explored the antimicrobial potential of purified secondary metabolites. Thus it is very important to conduct research in order to screen for and isolate antimicrobial substances, which researchers can then use to develop new antimicrobial drugs.

Articles with similar content:

Medicinal Mushrooms for Glycemic Control in Diabetes Mellitus: History, Current Status, Future Perspectives, and Unsolved Problems (Review)
International Journal of Medicinal Mushrooms, Vol.13, 2011, issue 5
Solomon P. Wasser, Hui-Chen Lo
Biotechnological Potential of Mushrooms: Drugs and Dye Production
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Girish Tidke, Mahendra K. Rai
The World Mushroom Industry: Trends and Technological Development
International Journal of Medicinal Mushrooms, Vol.8, 2006, issue 4
Shu-Ting Chang
Current and Future Research Trends in Agricultural and Biomedical Applications of Medicinal Mushrooms and Mushroom Products (Review)
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 12
Shu Ting Chang, Solomon P. Wasser
Medicinal Value of the Genus Pleurotus (Fr.) P.Karst. (Agaricales s.l., Basidiomycetes)
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 1
Nina Gunde-Cimerman